{"id":11064,"date":"2024-11-25T10:00:14","date_gmt":"2024-11-25T10:00:14","guid":{"rendered":"https:\/\/jubilantbiosys.com\/new-staging\/?page_id=11064"},"modified":"2026-02-22T19:34:35","modified_gmt":"2026-02-22T19:34:35","slug":"custom-protein-production","status":"publish","type":"page","link":"https:\/\/www.jubilantbiosys.com\/new-staging\/services\/custom-protein-production\/","title":{"rendered":"Custom Protein Production"},"content":{"rendered":"\n
\n
\n
\n

We are committed to providing high-level protein expression and purification services to produce quality recombinant proteins for our global customers through a flexible production scale model. With advanced workflow and technology, we work in partnership with our clients to meet their customized expression and purification needs and ensure high-throughput protein production, including recombinant antibodies for antibody drug conjugate<\/strong><\/a> development.<\/p>\n\n\n\n

Proteins are important biological macromolecules as they play key roles in almost every biological process of a living organism. Determining and understanding the 3D structure of a protein is essential for deciphering the mechanistic details about how a protein performs its activities.<\/p>\n\n\n\n

In small molecule drug discovery of any therapeutic area, it is a prerequisite to produce an enzymatically active recombinant protein that is equivalent to the native enzyme to understand its function\/activity in an in-vitro setting.<\/p>\n<\/div><\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n

Towards this, the Structural Biology team at Jubilant Biosys provides:<\/strong><\/p>\n\n\n\n

(A) enzymatically active recombinant soluble proteins, overexpressed from E. coli or baculovirus-insect cells or mammalian cells.<\/p>\n\n\n\n

(B) co-crystal structures of any soluble recombinant protein through X-ray crystallography using in-house X-ray diffraction facility, as well as accessing Australian Synchrotron beam.<\/p>\n\n\n\n

(C) stable cell lines that express protein-of-interest.<\/p>\n\n\n\n

This team has the experience of working with more than 20 pharmaceutical\/biotech companies worldwide and made the following success stories.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n

\n
\n
\n